| 000 | 01490 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517163924.0 | ||
| 264 | 0 | _c20180426 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1873-5169 | ||
| 024 | 7 |
_a10.1016/j.peptides.2017.07.007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSubramaniam, Venkat | |
| 245 | 0 | 0 |
_aPituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice. _h[electronic resource] |
| 260 |
_bPeptides _cSep 2017 |
||
| 300 |
_a25-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiotoxicity _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHeart Injuries _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMitoxantrone _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aPituitary Adenylate Cyclase-Activating Polypeptide _xadministration & dosage |
| 650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aVentricular Dysfunction, Left _xchemically induced |
| 700 | 1 | _aChuang, Gin | |
| 700 | 1 | _aXia, Huijing | |
| 700 | 1 | _aBurn, Brendan | |
| 700 | 1 | _aBradley, Jessica | |
| 700 | 1 | _aMaderdrut, Jerome L | |
| 700 | 1 | _aCoy, David H | |
| 700 | 1 | _aVarner, Kurt J | |
| 773 | 0 |
_tPeptides _gvol. 95 _gp. 25-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.peptides.2017.07.007 _zAvailable from publisher's website |
| 999 |
_c27380109 _d27380109 |
||